US 7,470,715 B2
	Estrogen modulators
Simon Bailey, San Diego, Calif. (US); Stephen Douglas Barrett, Hartland, Mich. (US); Raj Kumar Raheja, Ann Arbor, Mich. (US); and Veerabahu Shanmugasundaram, Novi, Mich. (US)
Assigned to Pfizer Inc., New York, N.Y. (US)
Filed on Dec. 19, 2006, as Appl. No. 11/612,582.
Claims priority of provisional application 60/805233, filed on Jun. 20, 2006.
Claims priority of provisional application 60/752780, filed on Dec. 22, 2005.
Prior Publication US 2007/0149564 A1, Jun. 28, 2007
Int. Cl. C07D 261/02 (2006.01); A61K 31/42 (2006.01)

U.S. Cl. 514—378  [514/341; 514/183]

5 Claims

1. (±)-4-{5-[1-(1-Hydroxy-ethyl)-cyclopropyl]-4-phenyl-isoxazol-3-yl}-phenol, or a pharmaceutically acceptable salt thereof.